Breaking Convention Series: Dr. Torsten Passie - The Science of Microdosing Psychedelics episode artwork

EPISODE · Jul 30, 2019 · 1H 22M

Breaking Convention Series: Dr. Torsten Passie - The Science of Microdosing Psychedelics

from Psychedelics Today

Download In this episode, Kyle sits down with Dr. Torsten Passie, Professor of Psychiatry and Psychotherapy with the Hanover Medical School in Germany. In the show, they cover a range of topics on Dr. Passie's studies on microdosing. Dr. Torsten Passie will be taking part in a special panel dedicated to microdosing at Breaking Convention 2019 (August 16-18, Greenwich, London), also featuring Amanda Fielding of the Beckley Foundation, Dr David Erritzoe of Imperial College, London, Dr Devin Turhune (Goldsmiths), and Dimitris Liokaftos, exploring myriad aspects of microdosing, including its effects, unknowns, and media representation presented by BC director Nikki Wyrd. Find out more about Breaking Convention: https://www.breakingconvention.co.uk/ 3 Key Points: Psychedelic research in the University setting died off after 2004, but is finally seeing an increase as the psychedelic revolution continues to grow. There is very little to no documentation of doctors doing self-experimenting with psychedelic drugs. It's becoming popular for therapists to use the substances used on their patients, more common to do the self-work before doing the work on others. Even if microdosing does not produce any significant effects and it is all placebo, the trend is a new way to introduce it into our society. The Science of Microdosing Psychedelics Support the show Patreon Leave us a review on iTunes Share us with your friends – favorite podcast, etc Join our Facebook group - Psychedelics Today group – Find the others and create community. Navigating Psychedelics Trip Journal                                              Integration Workbook Show Notes About Dr. Passie Dr. Passie has been researching psychedelics for 25 years He specializes in the therapeutic use of psychedelic drugs He has found difficulties in researching psychedelics during prohibition Dr. Passie had a mystical experience before using psychedelics and then became interested in psychedelic use He had grown up as an atheist, a materialist, and his experience required him to change his psychological state His perception of reality was irritated and he had to see a therapist to integrate this experience He said that this was frustrating because he was young and still in search for his identity Through all of this, he decided to study medicine and become a psychedelic doctor He became very conscious that he was on the right track Research Studies The researchers were the only ones doing studies on psychedelic states, there wasn't much happening at the Universities He did studies with cannabis, ketamine and even laughing gas The research then was on how cannabinoids can help with psychosis They were not successful with that, but it came to be that CBD was a neuroleptic and an anti-psychotic Research pretty much stopped after 2004 due to new laws and the cost of the research Dr. Passie does mention that in the past 10 years research has really taken off again and that we are really seeing the renaissance of psychedelic culture In most of the literature of doctors doing self-experimenting, there is very little to no documentation of doctors doing self-experimenting with psychedelic drugs Kyle mentions that MAPS has included into their training protocol to allow for therapists to have self-experiments with the substances that they are using on patients Kyle also mentions he can't imagine trying to hold space in breathwork without having had his own experiences with breathwork Dr. Passie says that the history of self-experimentation with psychedelics has shown that the participants can become 'gurus' and lose their objectivity, he uses Timothy Leary as an example But with only a few times of self-experimentation, maybe 2-4 times, he doesn't see risks HPPD Hallucinogen persisting perception disorder (HPPD) is a disorder in which a person has flashbacks of visual hallucinations or distortions experienced during a previous hallucinogenic drug experience Dr. Passie thinks there is a selection bias in what is published about HPPD Its more common to have a study published that talks about an adverse effect of LSD than a benefit of it Hundreds of thousands of studies were conducted in the 50's, and no one claimed that this phenomenon came up And now one person has conducted a study, claiming that this phenomena exists Dr. Passie says that this pattern happens among people who are prone to anxiety and who are dissociative He says that most subjects that claim to experience HPPD, have experienced visuals even before ever taking LSD Microdosing It has been known to not have any effects from 15-20 micrograms of LSD 20-50 micrograms of LSD is considered mini-dosing, where you can feel some type of effects from it, but not as much as the full dose Dr. Passie says it is strange for people to claim to have increased cognition during microdosing based on conventional data that shows that LSD produces poor cognitive function He thinks that whatever the effects are of LSD at a high dose, that the effects at a low dose are the same, just less, not completely different effects He believes that there is some placebo effect with microdosing In terms of the microdosing trend, Dr. Passie is critical about the productivity factor, he does believe in the creativity factor though The flow state may also be increased with microdosing He claims that in his own experience with microdosing, he doesn't experience the flow state, in fact he experiences a feeling of agitation Combinations In a study, when patients took a microdose first, and then a little while later, they took a different full psychedelic dose, the microdose impacted the experience of the full dose It lessened the effects of the full dose psychedelic Psychedelics and Sleep Dr. Passie mentions a study where patients were given LSD, both high and low doses, during sleep What was found was that LSD impacts REM sleep patterns The dreams were not altered The REM phases got longer during the beginning of sleep, and then much shorter near the end of sleep It shows that the impact of sleeping patterns brings someone to feel much different the next day The Microdosing Trend Microdosing has much to be explored yet But even if microdosing does not produce effects, the trend is a new way to introduce it into our society "Microdosing might be a new assimilation process of psychedelics into our culture" - Torsten Instead of the 60's where we are taking huge doses, we are taking tiny doses as a slow approach to assimilate psychedelics back into society Links The Science of Microdosing Psychedelics About Dr. Torsten Passie Torsten is a professor of psychiatry and psychotherapy affiliated with Hannover Medical School, and led the Laboratory for Consciousness and Neurocognition. He has conducted clinical research on psychoactive substances and has written several books including The Pharmacology of LSD (2010) and Healing with Entactogens (2012). Between 2012 and 2015 he was visiting professor at Harvard Medical School.

NOW PLAYING

Breaking Convention Series: Dr. Torsten Passie - The Science of Microdosing Psychedelics

0:00 1:22:12

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Chewing the Fat with WorkForge WorkForge Bite-Sized Conversations for Building a Stronger Workforce Welcome to Chewing the Fat, a podcast delving deep into the world of food manufacturing. Dive into real conversations around critical topics like staffing, retention, onboarding, and career development in this essential industry. Subscribe now to gain insights from your peers, subject matter experts and more on the biggest issues facing food manufacturers today: -Hiring and retaining employees -Addressing the challenges of the Silver Tsunami -Improving time to productivity of new employees -Engaging employees from hire to retire And more... Tune in to Chewing the Fat, a WorkForge podcast, and join the conversation on how to build and sustain a resilient, high-performing workforce in food manufacturing. She’s a Hazard to Herself She’s a Hazard Hi there, I’m Mallory, and I’d like to invite you into our world with “She’s a Hazard to Herself!” Join us as we navigate life with Multiple Sclerosis from the seat of my power wheelchair. Discover stories of resilience, family, and the community we’ve built around chronic illness. Whether you’re impacted by MS or want to learn from our journey, there’s something here for you. So why wait? Subscribe to “She’s a Hazard to Herself” on your favorite podcast app and be part of our journey today. Let’s lift each other up, one episode at a time! The Health Odyssey: Navigating Tomorrow's Medicine Podcast Welcome to 'The Health Odyssey: Navigating Tomorrow's Medicine,' where we embark on an adventurous journey through the ever-evolving world of healthcare. Each episode is like a treasure map, guiding you through the rich tapestry of ancient healing arts mixed with futuristic tech wizardry. We’ll chat about the wild west of health data privacy, the corporate giants reshaping our care, and the mind-bending potential of psychedelics for mental wellness. Think of us as your trusty sidekicks, unraveling the mysteries of modern medicine while keeping it real and relatable. Let’s dive into the stories, the science, and the soul of healthcare, paving the way for a healthier tomorrow. MySwimPro Swimming Technique & Training Podcast MySwimPro MySwimPro is the number one fitness application for the fastest growing sport in the world. Since 2014, we have been on a mission to help swimmers of all levels live happier and healthier lives through swimming. Today, swimmers in more than 150 countries use MySwimPro’s award-winning mobile and wearable apps to access personalized swim workout plans, training plans, educational drills and videos, advanced analytics, and to log and track their progress. MySwimPro is accessible on iOS and Android smartphones and wearables, and is free to get started.

Frequently Asked Questions

How long is this episode of Psychedelics Today?

This episode is 1 hour and 22 minutes long.

When was this Psychedelics Today episode published?

This episode was published on July 30, 2019.

What is this episode about?

Download In this episode, Kyle sits down with Dr. Torsten Passie, Professor of Psychiatry and Psychotherapy with the Hanover Medical School in Germany. In the show, they cover a range of topics on Dr. Passie's studies on microdosing. Dr. Torsten...

Can I download this Psychedelics Today episode?

Yes, you can download this episode by clicking the download button on the episode player, or subscribe to the podcast in your preferred podcast app for automatic downloads.
URL copied to clipboard!